CGNXCognex Corporation
$62.92+36% 1Y
$62.92
$34.7052 weeks$71.55
CGNX as reported
Cognex Corporation reported $1.09B of revenue over the trailing twelve months, +17% on the year before. 10 reported series are charted on this page, each one as filed.
$1.09B
Revenue, trailing twelve months · to Q2 2026 · +17% against the twelve months before
- Net income
- $175M
Net income · +43% year on year · trailing twelve months to Q2 2026
- Free cash flow
- $268M
Free cash flow · +49% year on year · trailing twelve months to Q2 2026
- Operating margin
- 22%
Operating margin · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $1.09B | +17% | Q2 2026 |
| Net income | $175M | +43% | Q2 2026 |
| EPS | $1.04 | +44% | Q2 2026 |
| Gross margin | 69% | n/a | Q2 2026 |
| Operating margin | 22% | n/a | Q2 2026 |
| Net margin | 16% | n/a | Q2 2026 |
| ROE | 8.9% | n/a | Q2 2026 |
| ROA | 6.6% | n/a | Q2 2026 |
| Free cash flow | $268M | +49% | Q2 2026 |
| P/E | 60.5 | n/a | today |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Cognex Corporation (CGNX) · Revenue and profitRevenue and profitCognex Corporation (CGNX)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
Scientific & Technical Instruments
Ranks #8 of 12 by RyuScore